• 항공우주의학회지
• /
• 제31권1호
• /
• pp.13-16
• /
• 2021

The coronavirus disease-19 (COVID-19) vaccine is expected to play an important role in stopping the pandemic. Studies show that COVID-19 vaccines are effective at keeping you from getting COVID-19. Getting a COVID-19 vaccine will also help keep you from getting seriously ill even if you do get COVID-19. Efforts to find an effective vaccine against severe acute respiratory syndrome coronavirus 2 have progressed unprecedentedly through active support from public research grants and private-public partnership programs. Clinical studies have been actively conducted, and some vaccines are being vaccinated with approval for urgent use. The WHO has approved and supplied the Pfizer-BioNTech COVID-19 vaccine and the Oxford-AstraZeneca COVID-19 vaccine. In Korea, the Oxford-AstraZeneca vaccine was approved for urgent use, and vaccination began on February 26, 2021. In this paper, the efficacy and side effects of each vaccines and the effect on pilots and air traffic controllers related to COVID-19 vaccination were investigated in terms of aviation medicine.

• 보건행정학회지
• /
• 제30권2호
• /
• pp.139-141
• /
• 2020

Coronavirus disease 2019 (COVID-19) is currently in progress. Although it is difficult to predict the end of currently increasing COVID-19, it is expected to last for a long time. The COVID-19 is making a lot of changes. Due to physical distancing and living distancing, non-contacts such as wearing facial masks, online lectures, online medical services, telecommuting, and telemarketing are becoming common. In the era of post-COVID-19, online and offline will coexist. Many countries following China's lockdown strategy, which is agreed with the World Health Organization, should be changed to Taiwan's facial mask strategy for reducing the economic problems. The prolonging COVID-19 will add to the economic difficulties, and the US-China confrontation will be difficult to rebound the global economy. COVID-19, such as plaque, smallpox, and Spanish influenza, will be a historical momentum. How to respond to the crisis of COVID-19 and post-COVID-19 will determine the future of the world and Korea.

• Journal of Preventive Medicine and Public Health
• /
• 제54권2호
• /
• pp.86-95
• /
• 2021

Objectives: This study investigated associations between perceptions of coronavirus disease 2019 (COVID-19) and the prevalence of posttraumatic stress disorder (PTSD) in workers at hospitals designated to treat COVID-19, as well as the difference in the magnitude of these associations by occupational type and previous Middle East respiratory syndrome coronavirus (MERS-CoV) experience. Methods: The participants were workers at hospitals designated to treat COVID-19 who completed a questionnaire about their perceptions related to COVID-19, work experience during the previous MERS-CoV outbreak, and symptoms of PTSD ascertained by the PTSD Checklist for the Diagnostic and Statistical Manual of Mental Disorders. Participants' characteristics were compared using the chi-square test. Multivariable logistic regression was performed to evaluate the associations between perceptions and the prevalence of PTSD, stratified by occupational type and previous MERS-CoV experience. Results: Non-medical personnel showed stronger associations with PTSD than medical personnel according to general fear (odds ratio [OR], 6.67; 95% confidence interval [CI], 1.92 to 23.20), shortages of supplies (OR, 1.29; 95% CI, 1.07 to 1.56), and issue-specific fear (OR, 1.29; 95% CI, 1.05 to 1.59). Those with prior MERS-CoV quarantine experience were more prone to PTSD than those without such experience in terms of general fear (OR, 1.70; 95% CI, 1.22 to 2.37), shortages of supplies (OR, 1.24; 95% CI, 1.10 to 1.40), and issue-specific fear (OR, 1.21; 95% CI, 1.06 to 1.38). Conclusions: During the COVID-19 pandemic, non-medical personnel tended to have higher odds of being categorized as having PTSD. Workers with prior MERS-CoV experience were more susceptible than those without such experience. These findings suggest the need for timely interventions to manage human resources for a sustainable quarantine system.

• International Journal of Computer Science & Network Security
• /
• 제22권6호
• /
• pp.39-44
• /
• 2022

The advent, course, and possible consequences of the COVID-19 pandemic are now the focus of global attention. From whichever side the geopolitical centers of influence might view it, the problem of the coronavirus concerns all world leaders and the representatives of all branches of science, especially physicians, economists, and politicians - virtually the entire population of the planet. The uniqueness of the COVID-19 phenomenon lies in the uncertainty of the problem itself, the peculiarities and specifics of the course of the biological processes in modern conditions, as well as the sharp confrontation of the main political players on the world stage. Based on an analysis of scientific research, the article describes the profile of the emotional concept of "anxiety" in Russian linguoculture. Through monitoring the headlines of Russian media reports in the "COVID-19" section of Google News and Mail News news aggregators dated August 4-6, 2021, the study establishes the quantitative and qualitative characteristics of the alarm-generating news products on coronavirus in the Russian segment of the Internet and interprets the specifics of media information about COVID-19. The level of mass media criticism in Russia is determined through a phone survey. It is concluded that coronavirus reports in online media conceptualize anxiety about the SARS virus and the COVID-19 disease as a complex cognitive structure. The media abuse the trick of "magic numbers" and emotionally expressive words in news headlines, which are perceived by mass information consumers first and typically uncritically.

• Journal of Microbiology and Biotechnology
• /
• 제30권8호
• /
• pp.1109-1115
• /
• 2020

The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading globally, and the WHO has declared this outbreak a pandemic. Vaccines are an effective way to prevent the rapid spread of COVID-19. Furthermore, the immune response against SARS-CoV-2 infection needs to be understood for the development of an efficient and safe vaccine. Here, we review the current understanding of vaccine targets and the status of vaccine development for COVID-19. We also describe host immune responses to highly pathogenic human coronaviruses in terms of innate and adaptive immunities.

• IMMUNE NETWORK
• /
• 제23권2호
• /
• pp.13.1-13.24
• /
• 2023

The coronavirus disease 2019 (COVID-19) pandemic is one of the most consequential global health crises in over a century. Since its discovery in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to mutate into different variants and sublineages, rendering previously potent treatments and vaccines ineffective. With significant strides in clinical and pharmaceutical research, different therapeutic strategies continue to be developed. The currently available treatments can be broadly classified based on their potential targets and molecular mechanisms. Antiviral agents function by disrupting different stages of SARS-CoV-2 infection, while immune-based treatments mainly act on the human inflammatory response responsible for disease severity. In this review, we discuss some of the current treatments for COVID-19, their mode of actions, and their efficacy against variants of concern. This review highlights the need to constantly evaluate COVID-19 treatment strategies to protect high risk populations and fill in the gaps left by vaccination.

• BMB Reports
• /
• 제55권1호
• /
• pp.11-19
• /
• 2022

The coronavirus disease 2019 (COVID-19) is an ongoing global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe COVID-19 exhibit hyper-inflammatory responses characterized by excessive activation of myeloid cells, including monocytes, macrophages, and neutrophils, and a plethora of pro-inflammatory cytokines and chemokines. Accumulating evidence also indicates that hyper-inflammation is a driving factor for severe progression of the disease, which has prompted the development of anti-inflammatory therapies for the treatment of patients with COVID-19. Corticosteroids, IL-6R inhibitors, and JAK inhibitors have demonstrated promising results in treating patients with severe disease. In addition, diverse forms of exosomes that exert anti-inflammatory functions have been tested experimentally for the treatment of COVID-19. Here, we briefly describe the immunological mechanisms of the hyper-inflammatory responses in patients with severe COVID-19. We also summarize current anti-inflammatory therapies for the treatment of severe COVID-19 and novel exosome-based therapeutics that are in experimental stages.

• Pediatric Infection and Vaccine
• /
• 제30권2호
• /
• pp.62-72
• /
• 2023

목적: Coronavirus disease 2019 (COVID-19) 발생 이후 인간 코로나바이러스를 포함한 호흡기 바이러스의 패턴에 변화가 있을 것으로 생각되어, COVID-19 발생 이전 경기도 명지병원에 급성 호흡기 감염증으로 입원한 소아청소년을 대상으로 바이러스 감염의 패턴을 보고하였다. 방법: 2017년 1월부터 2019년 12월까지 급성 호흡기 감염증으로 명지병원에 입원한 18세 이하 소아청소년을 대상으로 하였고 real-time reverse transcription polymerase chain reaction (RT-PCR) 결과를 바탕으로 후향적으로 의무기록을 고찰하였다. 결과: 총 3,557명 중에서 중복감염 포함하여 3,686건의 바이러스가 검출되었고 평균 양성률은 78.6%이었으며 여름에 비해 겨울에 PCR 양성률이 높았다. 파라인플루엔자바이러스, 메타뉴모바이러스, 보카바이러스는 4-6월에 주로 검출되고, 인간엔테로바이러스는 7-9월에, 호흡기세포융합바이러스와 인플루엔자바이러스는 겨울철에 주로 검출되었다. 진단별로 인두편도염에서는 아데노바이러스가 가장 많았고 폐렴에서는 호흡기세포융합바이러스가 가장 많이 검출되었다. 인간 코로나 바이러스는 겨울철에 주로 검출되었으며, 크루프 환자 중에서 3번째 높은 빈도로 나타났다. 결론: 본 연구결과가 이전에 보고되었던 소아청소년의 호흡기 바이러스 역학과 크게 다르지 않았다. 또한 COVID-19 발생 이후 호흡기 바이러스 패턴 비교 연구에 도움이 되고자 COVID-19 발생 이전 호흡기 바이러스 역학정보를 보고하는 바이다.

• 대한약침학회지
• /
• 제23권2호
• /
• pp.62-70
• /
• 2020

Coronavirus disease-19 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS CoV-2). Currently, the management of patients with COVID-19 depends mainly on repurposed drugs which include chloroquine, hydroxychloroquine, lopinavir/ritonavir, ribavirin, remdesivir, favipiravir, umifenovir, interferon-α, interferon-β and others. In this review, the potential of Nigella sativa (black cumin seeds) to treat the patients with COVID-19 analyzed, as it has shown to possess antiviral, antioxidant, anti-inflammatory, anticoagulant, immunomodulatory, bronchodilatory, antihistaminic, antitussive, antipyretic and analgesic activities. Medline/PubMed Central/PubMed, Google Scholar, Science Direct, Directory of open access journals (DOAJ) and reference lists were searched to identify articles associated with antiviral and other properties of N.sativa related to the signs and symptoms of COVID-19. Various randomized controlled trials, pilot studies, case reports and in vitro and in vivo studies confirmed that N.sativa has antiviral, antioxidant, anti-inflammatory, immunomodulatory, bronchodilatory, antihistaminic, antitussive activities related to causative oraganism and signs and symptoms of COVID-19. N. sativa could be used as an adjuvant therapy along with repurposed conventional drugs to manage the patients with COVID-19.

• 대한후두음성언어의학회지
• /
• 제33권3호
• /
• pp.156-159
• /
• 2022

The coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus-2 has upended the world of otolaryngology. After COVID-19 infection, patients experience various complication of symptoms due to injury of the larynx and lung/ respiratory system. Regardless of the patient's severity, patients can experience several complications including dysphonia, vocal cord paralysis/paresis and sensory neuropathy. An emerging role for otolaryngologists in the coming weeks and months is the management of laryngeal complications of COVID-19. This review is intended to describe laryngeal complications in patients recovering from COVID-19 infection.